How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?

Klodeta Kura(Imperial College London), Luc E. Coffeng(Erasmus MC), Wilma A. Stolk(Erasmus MC), Roy M. Anderson(Imperial College London), Benjamin Collyer(NIHR Imperial Biomedical Research Centre), Katherine Gass(The Task Force for Global Health), Peter J. Diggle(Lancaster University), Sake J. de Vlas(Erasmus MC), María‐Gloria Basáñez(Liverpool School of Tropical Medicine), Jonathan D. King(World Health Organization), T. Déirdre Hollingsworth(University of Oxford), Matthew Graham(University of Oxford), Alison Krentel(University of Ottawa)
Clinical Infectious Diseases
April 25, 2024
Cited by 14


Related Papers